A115 CLINICAL, RADIOGRAPHIC, AND ENDOSCOPIC REMISSION WITH VEDOLIZUMAB TREATMENT IN CROHN’S DISEASE

BACKGROUND: Vedolizumab is a gut-specific alpha-4-beta-7 integrin antagonist that has demonstrated efficacy in induction and maintenance of clinical response and remission in Crohn’s disease randomized controlled trials. AIMS: To evaluate the symptomatic and objective response and remission rates ac...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Can Assoc Gastroenterol
Päätekijät: Kotze, P, Ma, C, Almutairdi, A, Al-Darmaki, A, Devlin, S, Kaplan, G G, Seow, C, Novak, K L, Lu, C, Ferraz, J, Stewart, M J, Buresi, M c, Mathivanan, M, Heatherington, J, Martin, M, Panaccione, R
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Paper Sessions
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6508214/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.115
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia